With every passing day, new discoveries are made that lend support to the increasing and important role biomarker analysis and tumor profiling play in personalized cancer care. Caris Life Sciences® is actively participating in research to advance the understanding of molecular science, further enabling the delivery of precision medicine.

Molecular Variances Between Rectal and Left-Sided Colon Cancers

Molecular Characterization of Early vs. Late Onset Gastroesophagel Cancer

Racial differences in the molecular landscape of breast

Predictive Biomarker Profiling of > 6000 Breast Cancer Patients Shows Heterogeneity in TNBC, With Treatment Implications

Adaptive dynamic artificial polyligand targeting (ADAPT) A Method to identify exosomal proteins from a prostate cancer cell line

PD-1 and PD-L1 expression in 1599 gynecological malignancies – implications for immunotherapy

Predictive biomarker profiling of > 1,900 sarcomas: Identification of potential novel treatment modalities

Potential actionable targets in appendiceal cancer detected by immunohistochemistry (IHC), fluorescent in situ hybridiza&on (FISH) and mutational analysis.

Paget’s disease biomarkers differences between extra-mammary and mammary diseases

Profiling of metastatic cancers to the breast for the biomarkers of immuno-oncology therapy